Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Suannutra, Myota Partner to Distribute Prebiotic Ingredients in U.S., U.K., and E.U. - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Suannutra, Myota Partner to Distribute Prebiotic Ingredients in U.S., U.K., and E.U.

Myota’s flagship blend of nine plant-based fibers is formulated to support metabolic health.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Suannutra

Suannutra, a global nutraceutical ingredient supplier, has entered into an exclusive distribution agreement with Myota to introduce its prebiotic fiber blends, including its flagship Metabolic Regulator ingredient, to the U.S., U.K., and E.U. markets.

Metabolic Regulator is a blend of nine plant-based fibers, evidenced to promote the production of short-chain fatty acids (SCFAs) through targeted fermentation by gut microbes. It is also associated with blood sugar benefits, maintaining healthy cholesterol levels, and minimizing post-meal glucose spikes. The low-FODMAP formulation is suitable for those with digestive sensitivities.

Suannutra’s flagship ingredient, Metabolaid, can complement this ingredient by indirectly supporting SCFA generation via microbiome modulation.

Metabolaid also activates the AMPk pathway, which is associated with promoting levels of energy, and can also help to maintain healthy lipid metabolism and blood pressure, per the company.

“This partnership enhances our portfolio with targeted microbiome-nourishing solutions, providing next-gen support for cardiometabolic wellness,” said Anthony Weston, CEO of Suannutra. “By combining Metabolaid’s support of key metabolic pathways with Myota’s microbiome-driven prebiotic approach, we’re delivering a complementary dual-action approach to today’s metabolic health needs.”

“We see immense value in pairing our fermentation-optimized prebiotics with Suannutra’s clinically vetted actives,” said Thomas Gurry, PhD, CEO of Myota. “Together, we are shifting the paradigm from generic gut health to precision-formulated, systemic wellness.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics